Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001974158-25-000091
Filing Date
2025-12-19
Accepted
2025-12-19 16:32:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5756
  Complete submission text file 0001974158-25-000091.txt   7207
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Subject) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39247 | Film No.: 251588010
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address
Lyssikatos Joseph P (Reporting) CIK: 0001967150 (see all company filings)

Type: 144